本文選題：糖尿病　切入點：成骨細(xì)胞　出處：《泰山醫(yī)學(xué)院》2012年碩士論文　論文類型：學(xué)位論文

【摘要】：目的 觀察糖尿人來源的成骨細(xì)胞與胰島素對人臍帶間充質(zhì)干細(xì)胞成骨分化的影響，，探討人臍帶間充質(zhì)干細(xì)胞治療糖尿病人骨折愈合延遲的可行性。 方法 一、成骨細(xì)胞的分離與培養(yǎng)：利用膠原酶消化法分離培養(yǎng)人成骨細(xì)胞，利用堿性磷酸酶鈣鈷法染色、Ⅰ型膠原蛋白免疫細(xì)胞化學(xué)染色、鈣結(jié)節(jié)茜素紅染色鑒定成骨細(xì)胞的特性。 二、成骨細(xì)胞對臍帶間充質(zhì)干細(xì)胞成骨分化的影響：利用Transwell細(xì)胞培養(yǎng)板，間接共培養(yǎng)成骨細(xì)胞與臍帶間充質(zhì)干細(xì)胞。實驗分三組，A組上室不加細(xì)胞作為陰性對照組；B組上室內(nèi)放置非糖尿病人來源的成骨細(xì)胞；C組上室內(nèi)放置糖尿病人來源的成骨細(xì)胞；三組下室內(nèi)均放置人臍帶間充質(zhì)干細(xì)胞。采用CCK-8法于第一周內(nèi)觀察臍帶間充質(zhì)干細(xì)胞的生長增殖情況；第10天時行免疫熒光染色，觀察Ⅰ型膠原蛋白的表達(dá)情況；第7、10、14天時利用細(xì)胞堿性磷酸酶活性比色法觀察臍帶間充質(zhì)干細(xì)胞內(nèi)的堿性磷酸酶活性表達(dá)情況；利用RT-PCR的方法在第21天時，觀察臍帶間充質(zhì)干細(xì)胞內(nèi)骨鈣素mRNA的相對表達(dá)量。 三、胰島素對臍帶間充質(zhì)干細(xì)胞分化的影響：實驗分為胰島素處理組與非胰島素處理組，利用CCK-8法觀察臍帶間充質(zhì)干細(xì)胞的增殖情況；細(xì)胞堿性磷酸酶活性比色法比較臍帶間充質(zhì)干細(xì)胞內(nèi)堿性磷酸酶活性；RT-PCR法比較臍帶間充質(zhì)干細(xì)胞內(nèi)Ⅰ型膠原蛋白mRNA、骨鈣素mRNA的相對表達(dá)量。 結(jié)果 一、所培養(yǎng)的細(xì)胞表達(dá)堿性磷酸酶，Ⅰ型膠原蛋白和鈣結(jié)節(jié)，符合成骨細(xì)胞的特征，同非糖尿病人來源的成骨細(xì)胞相比，糖尿病人來源的成骨細(xì)胞表達(dá)的堿性磷酸酶、Ⅰ型膠原蛋白、鈣結(jié)節(jié)量少。 二、A組的臍帶間充質(zhì)干細(xì)胞的增殖較慢；B、C組的臍帶間充質(zhì)干細(xì)胞增殖較快，B組的細(xì)胞數(shù)量多于A、C兩組，三組間的差異具有統(tǒng)計學(xué)意義（P0.05）。 三、臍帶間充質(zhì)干細(xì)胞在第10天時行Ⅰ型膠原蛋白免疫熒光染色，A組為陰性，B、C組呈陽性，B、C兩組間的差異無統(tǒng)計學(xué)意義（P0.05）。 四、A組堿性磷酸酶活性一直處于低表達(dá)狀態(tài)，同A組相比，B、C組堿性磷酸酶活性增加，10天時達(dá)到高峰，14天時表達(dá)降低，B、C組堿性磷酸酶活性表達(dá)趨勢相同，但C組表達(dá)量低，三組間的差異具有統(tǒng)計學(xué)意義（P0.05）。 五、在第21天時，RT-PCR檢測發(fā)現(xiàn)B、C組的臍帶間充質(zhì)干細(xì)胞內(nèi)表達(dá)骨鈣素基因，A組未檢測到骨鈣素基因的表達(dá)，C組表達(dá)量低于B組表達(dá)量，三組間的差異具有統(tǒng)計學(xué)意義（P0.05）。 六、同非胰島素處理組相比，胰島素處理組臍帶間充質(zhì)干細(xì)胞的增殖加快，堿性磷酸酶活性增高，Ⅰ型膠原蛋白基因、骨鈣素基因表達(dá)量高，兩者間的差異具有統(tǒng)計學(xué)意義（P0.05）。 結(jié)論 糖尿病人來源的成骨細(xì)胞雖然功能受損，但是具有誘導(dǎo)臍帶間充質(zhì)干細(xì)胞成骨分化的能力，其誘導(dǎo)分化作用略差于非糖尿病人來源的成骨細(xì)胞。胰島素不僅能夠促進(jìn)受損成骨細(xì)胞的功能恢復(fù)，并且促進(jìn)臍帶間充質(zhì)干細(xì)胞的增殖和成骨分化。因此推測臍帶間充質(zhì)干細(xì)胞聯(lián)合胰島素移植在促進(jìn)糖尿病人的骨折修復(fù)領(lǐng)域中具有積極的作用。
[Abstract]:objective
Objective To observe the effect of diabetic human osteoblasts and insulin on the osteogenic differentiation of human umbilical cord mesenchymal stem cells, and to explore the feasibility of human umbilical cord mesenchymal stem cells in the treatment of diabetic patients with fracture healing delay.
Method
First, the isolation and culture of osteoblasts: isolation and culture of human osteoblasts by collagenase digestion. The characteristics of osteoblasts were identified by alkaline phosphatase cobalt cobalt staining, type I collagen immunocytochemical staining and calcium nodule alizarin red staining.
Two, the osteogenic effect of human umbilical cord mesenchymal stem cell into osteogenic differentiation: culture plate using Transwell cells, indirect co cultured osteoblasts and umbilical cord mesenchymal stem cells. The experiment was divided into three groups, A group on the room without cells as a negative control group; Osteoblasts group B was placed in the room without diabetic patient derived osteoblasts; group C was placed in the room of diabetic patients from three groups were placed indoors; human umbilical cord mesenchymal stem cells. In the first weeks of observation of umbilical cord mesenchymal stem cell proliferation by CCK-8 method; tenth days after immunofluorescence staining, we observed the expression of type I collagen the first 7,10,14 days; the alkaline phosphatase activity of cultured human umbilical cord mesenchymal stem cells in the expression of alkaline phosphatase activity assay; using RT-PCR method in twenty-first days, the observation of umbilical cord mesenchymal stem cells in osteocalcin mRN The relative expression of A.
Three, the effect of insulin on differentiation of umbilical cord mesenchymal stem cells: the experiment was divided into insulin group and non insulin treated group, observation of umbilical cord mesenchymal stem cell proliferation by CCK-8 method; alkaline phosphatase activity of the cells colorimetric method of umbilical cord mesenchymal stem cells alkaline phosphatase activity; RT-PCR method of umbilical cord mesenchymal mesenchymal stem cells in collagen type mRNA, the relative expression of osteocalcin mRNA.
Result
First, cultured cells expressed alkaline phosphatase, type I collagen and calcium nodules, which accords with the characteristics of osteoblasts. Compared with osteoblasts derived from non-diabetic patients, alkaline phosphatase, type I collagen and calcium nodules expressed in osteoblasts derived from diabetic patients were less.
Two, the proliferation of umbilical cord mesenchymal stem cells in A group was slower than that in group B; the proliferation of umbilical cord mesenchymal stem cells in group C and C was faster than that in group C, and the number of cells in B group was more than that in A group. The difference between C group was statistically significant (P0.05).
Three, human umbilical cord mesenchymal stem cells staining in tenth days were of type I collagen immunofluorescence, group A was negative, B, C group was positive, B, C was no significant difference between the two groups (P0.05).
Four, the A group has been in the low expression of alkaline phosphatase activity, compared with the A group, B group, C increased alkaline phosphatase activity, reached the peak on day 10, day 14 decreased expression of B, C group expression of alkaline phosphatase activity the same trend, but the C low expression group, and the difference between the three groups with statistical significance (P0.05).
Five, on the twenty-first day, RT-PCR detected the expression of osteocalcin gene in umbilical cord mesenchymal stem cells of B and C group. The expression of osteocalcin gene was not detected in group A, and the expression level in group C was lower than that in B group. The difference between the three groups was statistically significant (P0.05).
Six, compared with the non insulin treatment group, the proliferation of umbilical cord mesenchymal stem cells and the activity of alkaline phosphatase in the insulin treatment group increased. The expression of type I collagen gene and osteocalcin gene was high, and the difference between them was statistically significant (P0.05).
conclusion
Diabetic osteoblasts although the function is impaired, but can induce human umbilical cord mesenchymal stem cells differentiated into bone, bone cells and the differentiation effect is slightly worse than the non diabetes sources. Insulin can not only promote the recovery of bone cells into damaged function, and promote the umbilical cord mesenchymal stem cells the proliferation and osteogenic differentiation. So we speculate that umbilical cord mesenchymal stem cells transplantation combined with insulin plays a positive role in promoting fracture repair in patients with diabetes in the field.

【學(xué)位授予單位】：泰山醫(yī)學(xué)院
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2012
【分類號】：R587.1;R329

【共引文獻(xiàn)】

相關(guān)期刊論文 前4條

1 陸德云,趙連三;臍血間充質(zhì)干細(xì)胞向肝細(xì)胞誘導(dǎo)分化的研究進(jìn)展[J];四川醫(yī)學(xué);2005年10期

2 孫愛紅,馮四洲,馮義,張磊,盧士紅,韓忠朝;臍血CD_(34)~-單個核細(xì)胞來源間充質(zhì)干細(xì)胞研究[J];中國生物工程雜志;2004年06期

3 唐曉瓊;趙智剛;王紅祥;李秋柏;鄒萍;;人臍靜脈來源的間質(zhì)干細(xì)胞體外分離擴(kuò)增及多向分化的研究[J];中國病理生理雜志;2006年10期

4 孫愛紅,馮四洲,馮義,張磊,盧士紅,韓忠朝;臍血間充質(zhì)干細(xì)胞鑒定及其生物學(xué)特性研究[J];中華血液學(xué)雜志;2004年08期

相關(guān)博士學(xué)位論文 前4條

1 孫愛紅;臍血源貼壁細(xì)胞生物學(xué)特性和單個核細(xì)胞骨髓腔內(nèi)移植NOD/SCID小鼠實驗研究[D];中國協(xié)和醫(yī)科大學(xué);2004年

2 陸德云;1.阿德福韋酯治療拉米夫定耐藥HBeAg（+）慢性乙肝的臨床研究 2.重型肝炎患者血漿對體外培養(yǎng)臍血間充質(zhì)干細(xì)胞影響的初步研究[D];四川大學(xué);2006年

3 王琪;人臍帶血間充質(zhì)干細(xì)胞復(fù)合β-磷酸三鈣的骨組織工程學(xué)實驗研究[D];第二軍醫(yī)大學(xué);2007年

4 田新;臍血及臍帶靜脈內(nèi)皮下間充質(zhì)干細(xì)胞的分離擴(kuò)增與分化[D];四川大學(xué);2007年

相關(guān)碩士學(xué)位論文 前4條

1 張鵬;人臍血間充質(zhì)干細(xì)胞移植治療腦創(chuàng)傷大鼠的實驗研究[D];鄭州大學(xué);2005年

2 李恩;人臍血間充質(zhì)干細(xì)胞移植治療脊髓損傷的實驗研究[D];鄭州大學(xué);2007年

3 曾妍;補(bǔ)益中藥促進(jìn)臍血干細(xì)胞生長分化為肝細(xì)胞的實驗研究[D];中南大學(xué);2007年

4 李璋;胎盤來源多能細(xì)胞的體外分離培養(yǎng)與生物學(xué)特性研究[D];四川大學(xué);2007年

本文編號：1606622